Skip to main content
SpringerLink
Log in

Prevalence and clinical associations of anticardiolipin antibodies in systemic lupus erythematosus: A prospective study

  • Originals
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

The main objectives of the present study were to determine the prevalence of IgG and IgM anticardiolipin antibody (aCL) isotypes in systemic lupus erythematosus (SLE) in order to analyze their possible association with the clinical manifestations of the disease. Clinical features of 64 consecutive and unselected SLE patients were prospectively studied. Sera from the same patients taken during each clinical manifestation were tested for the presence of aCL. The prevalence of aCL was 43.75% for the IgG isotype and 9.4% for the IgM isotype. A strong linkage between the presence of these antibodies and the occurrence of both thrombosis and abortions was found: a weaker association with neurological events and thrombocytopenia was also demonstrated. The titre of aCL appeared to be linked with the probability of having the clinical manifestations associated with these autoantibodies. Our results suggest that thrombosis and abortion, and possibly thrombocytopenia and central nervous system involvement, may be associated with the presence of aCL at the time when these clinical events develop in SLE patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Feinstein, D.I., Rapaport, S.I. Acquired inhibitors of blood coagulation. Prog Hemost Thromb 1972, 1, 75–95.

    PubMed  Google Scholar 

  2. Shapiro, S.S., Thigarajan, P. Lupus anticoagulants. Prog Hemost Thromb 1982, 6, 263–85.

    PubMed  Google Scholar 

  3. Derksen, R.H., Kater, L. Lupus anticoagulant: revival of an old phenomenon. Clin Exp Rheumatol 1985, 3, 349–57.

    PubMed  Google Scholar 

  4. Harris, E.N., Hughes, G.R., Gharavi, A.E. Anti-cardiolipin antibodies and the lupus anticoagulant. Clin Exp Rheumatol 1986, 4, 187–90.

    PubMed  Google Scholar 

  5. Harris, E.N., Asherson, R.A., Hughes, G.R. Antiphospholipid antibodies-autoantibodies with a difference. Ann Rev Med 1988, 39, 261–71.

    PubMed  Google Scholar 

  6. Asherson, R.A., Harris, E.N. Anticardiolipin antibodies-clinical associations. Postgrad Med J 1986, 62, 1081–7.

    PubMed  Google Scholar 

  7. Hughes, G.R.V., Harris, E.N., Gharavi, A.E. The anticardiolipin syndrome. J Rheumatol 1986, 13, 486–9.

    PubMed  Google Scholar 

  8. Lubbe, W.F., Butler, W.S., Liggins, G.C. The lupus-anticoagulant: clinical and obstetric implications. N Z Med J 1984, 97, 398–402.

    PubMed  Google Scholar 

  9. Feinstein, D.I. Lupus anticoagulant, thrombosis and fetal loss (Editorial). N Engl J Med 1985, 313, 1348–9.

    PubMed  Google Scholar 

  10. Levine, S.R., Welch, K.M. The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulants and anticardiolipin antibodies. Arch Neurol 1987, 44, 876–83.

    PubMed  Google Scholar 

  11. Mueh, J.R., Herbst, K.D., Rapaport, S.I. Thrombosis in patients with the lupus anticoagulant. Ann Intern Med 1980, 92, 156–9.

    PubMed  Google Scholar 

  12. Boey, M.L., Colaco, C.B., Gharavi, A.E., Elkon, K.B., Loizou, S., Hughes, G.R.V. Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant. Br Med J 1983, 287, 1021–3.

    Google Scholar 

  13. Harris, E.N., Chan, J.K.H., Asherson, R.A., Aber, V.R., Gharavi, A.E., Hughes, G.R.V. Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med 1986, 146, 2153–6.

    PubMed  Google Scholar 

  14. Derue, G., Englert, H., Harris, E.N. Fetal loss in systemis lupus: association with anticardiolipin antibodies. J Obstet Gynecol Neonatal Nurs 1985, 2, 207–9.

    Google Scholar 

  15. Lockshin, M.D., Druzin, M.L., Goei, S., Qamar, T., Magid, M.S., Jovanovic, L., Fereno, M. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 1985, 313, 152–6.

    PubMed  Google Scholar 

  16. Delezé, M., Alarcon-Segovia, D., Oria, C.V. Occurrence of both hemolytic anemia and thrombocytopenic purpura (Evans syndrome) in systemic lupus erythematosus. Relationship to antiphospholipid antibodies. J Rheumatol 1988, 15, 611–5.

    PubMed  Google Scholar 

  17. Asherson, R.A., Mercey, D., Phillips, G., Sheehan, N., Gharavi, A.E., Harris, E.N., Hughes, G.R.V. Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies. Ann Rheum Dis 1987, 46, 605–11.

    PubMed  Google Scholar 

  18. Khamashta, M.A., Gil, A., Anciones, B., Lavilla, P., Valencia, M.E., Pintado, V., Vazquez, J.J. Chorea in systemic lupus erythematosus: association with antiphospholipid antibodies. Ann Rheum Dis 1988, 47, 681–3.

    PubMed  Google Scholar 

  19. Manoussakis, M.N., Gharavi, A.E., Drosos, A.A., Kitridou, R.C., Moutsopoulos, H.M. Anticardiolipin antibodies in unselected autoimmune rheumatic disease patients. Clin Immunol Immunopathol 1987, 44, 297–307.

    PubMed  Google Scholar 

  20. Sturfelt, G., Nived, O., Norsberg, R., Thorstensson, R., Crook, K. Anticardiolipin antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 1987, 30, 382–8.

    PubMed  Google Scholar 

  21. Petri, M., Golbus, M., Anderson, R., Whiting-O'Kneefe, Q., Corash, L., Hellmann, D. Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. Arthritis Rheum 1987, 30, 601–6.

    PubMed  Google Scholar 

  22. Love, P.E., Santoro, S.A. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med 1990, 112, 682–98.

    PubMed  Google Scholar 

  23. Harris, E.N., Gharavi, A.E., Boey, M.L., Patel, B.M., Mackworth-Young, C.G., Loizou, S., Hughes, G.R.V. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983, ii, 1211–1214.

    Google Scholar 

  24. Loizou, S., McCrea, J.D., Rudge, A.C., Reynolds, R., Boyle, C.C., Harris, E.N. Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results. Clin Exp Immunol 1985, 62, 738–45.

    PubMed  Google Scholar 

  25. Gharavi, A.E., Harris, E.N., Asherson, R.A., Hughes, G.R.V. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis 1987, 46, 1–6.

    PubMed  Google Scholar 

  26. Derksen, R.H.W.M., Hasselaar, P., Blokzijl, L., Gmelig Meyling, F.H.J., De Groot, P.G. Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients. Ann Rheum Dis 1988, 47, 364–71.

    PubMed  Google Scholar 

  27. Colaco, C.B., Male, D.K. Anti-phospholipid antibodies in syphilis and a thrombotic subset of SLE: distinct profiles of epitope specificity. Clin Exp Immunol 1985, 59, 449–56.

    PubMed  Google Scholar 

  28. Tan, E.M., Cohen, A.S., Fries, J.F., Masi, A.T., McShane, D.J., Rothfield, N.F., Schaller, J.G., Talal, N., Winchester, R.J. The 1982 revised criteria for the classification of SLE. Arthritis Rheum 1982, 25, 1271–7.

    PubMed  Google Scholar 

  29. Harris, E.N., Gharavi, A.E., Patel, S.P., Hughes, G.R.V. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987, 68, 215–22.

    PubMed  Google Scholar 

  30. Petri, M., Rheinschmidt, M., Whiting-O'Kneefe, Q., Hellman, D., Corash, L. The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russel viper venom time, and anticardiolipin antibody level. Ann Intern Med 1987, 106, 524–31.

    PubMed  Google Scholar 

  31. Fort, J.G., Cowchock, F.S., Abruzzo, J.L., Smith, J.B. Anticardiolipin antibodies in patients with rheumatic diseases. Arthritis Rheum 1987, 30, 752–60.

    PubMed  Google Scholar 

  32. Harris, E.N., Asherson, R.A., Gharavi, A.E., Morgan, S.H., Derue, G., Hughes, G.R. Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibodies. Br J Haematol 1985, 59, 227–30.

    PubMed  Google Scholar 

  33. Aster, R.H. The immunologic thrombocytopenias. In: Platelet Immunobiology: Molecular and Clinical Aspects, Eds: Kunicki, T.J., George, J.N., Philadelphia, Lippincott, J.B., 1989, 387–435.

    Google Scholar 

  34. Harris, E.N., Gharavi, A.E., Hughes, G.R.V. Antiphospholipid antibodies. Clin Rheum Dis 1985, 11, 591–609.

    PubMed  Google Scholar 

  35. Khamashta, M.A., Harris, E.N., Gharavi, A.E., Derue, G., Gil, A., Vazquez, J.J., Hughes, G.R.V. Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes. Ann Rheum Dis 1988, 47, 849–54.

    PubMed  Google Scholar 

  36. van Leeuwen, E.F., van der Ven, J.T., Engelfriet, C.P., von dem Borne, A.E. Specificity of autoantibodies in autoimmune thrombocytopenia. Blood 1982, 59, 23–6.

    PubMed  Google Scholar 

  37. Woods, V.L.Jr., Oh, E.H., Mason, D., McMillan, R. Autoantibodies against the platelet glycoprotein IIb/IIIa complex in patients with chronic ITP. Blood 1984, 63, 368–75.

    PubMed  Google Scholar 

  38. Beardsley, D.S., Spiegel, J.E., Jacobs, M.M., Handin, R.I., Lux, S.E.IV. Platelet membrane glycoprotein IIIa contains target antigens that bind anti-platelet antibodies in immune thrombocytopenias. J Clin Invest 1984, 74, 1701–7.

    PubMed  Google Scholar 

  39. Khamashta, M.A., Cervera, R., Asherson, R.A., Font, J., Gil, A., Coltart, D.J., Vazquez, J.J., Pare, C., Ingelmo, M., Oliver, J., Hughes, G.R.V. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 1990, 335, 1541–44.

    PubMed  Google Scholar 

  40. Jan Out, H., De Groot, P.G., Hasselaar, P., Van Vliet, M., Derksen, R.H.W.M. Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective study. Ann Rheum Dis 1989, 48, 1023–28.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. II Cattedra di Reumatologia, Università “La Sapienza”, Via E. D'Arborea 26, 00162, Roma, Italia

    G. D. Sebastiani, G. Passiu & U. Carcassi

  2. Divisione di Reumatologia, Ospedale San Camillo De Lellis, Via E. D'Arborea 26, 00162, Roma, Italia

    M. Galeazzi & F. Porzio

Authors
  1. G. D. Sebastiani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Passiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Galeazzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. Porzio
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. U. Carcassi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sebastiani, G.D., Passiu, G., Galeazzi, M. et al. Prevalence and clinical associations of anticardiolipin antibodies in systemic lupus erythematosus: A prospective study. Clin Rheumatol 10, 289–293 (1991). https://doi.org/10.1007/BF02208692

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02208692

Key words

Search

Navigation